Brian G. Feagan

Western University — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

136h-index89.2kcitations1.3kworks5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(1021), Microscopic Colitis(685), Eosinophilic Esophagitis(186), Autoimmune and Inflammatory Disorders(128), Immunodeficiency and Autoimmune Disorders(120)

Publications1.3k total

An evaluation of guselkumab for the treatment of ulcerative colitis
Expert Opinion on Biological Therapy·2025· 1 cited
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn’s Disease
Clinical Gastroenterology and Hepatology·2025Open Access
Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers
Radiographics·2025· 1 citedOpen Access
Placebo rates in randomized clinical trials of ulcerative colitis: an individual patient data meta-analysis
Journal of Crohn s and Colitis·2025· 1 citedOpen Access
How Should an IBD Prevention Trial Be Designed?
Inflammatory Bowel Diseases·2025
Long-term efficacy and safety of tulisokibart in participants with ulcerative colitis: the open-label extension of the phase 2 ARTEMIS-UC study
Zeitschrift für Gastroenterologie·2025
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn’s Disease Postoperative Recurrence in the PREVENT trial
Clinical Gastroenterology and Hepatology·2025Open Access
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn’s Disease
Inflammatory Bowel Diseases·2025Open Access
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
Clinical Gastroenterology and Hepatology·2025· 1 cited
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
˜The œLancet. Gastroenterology & hepatology·2025· 9 citedOpen Access
Development and External Validation of an Endoscopic and Histologic Pouchitis Assessment Tool: The Atlantic Pouchitis Index
Clinical Gastroenterology and Hepatology·2025· 2 citedOpen Access
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion
Inflammatory Bowel Diseases·2025· 1 citedOpen Access
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials
˜The œLancet. Gastroenterology & hepatology·2025· 3 citedOpen Access
Diagnosis of Inflammatory Bowel Disease–Associated Peripheral Arthritis: A Systematic Review
UNC Libraries·2025Open Access
O15 Long-term efficacy and safety of tulisokibart in participants with ulcerative colitis: the open-label extension of the phase 2 ARTEMIS-UC study
Oral Presentations·2025
P13 Efficacy and safety results of tulisokibart re-induction treatment in participants with ulcerative colitis in the phase 2 ARTEMIS-UC clinical trial
2025
O21 Long-term efficacy and safety of filgotinib 200 mg in ulcerative colitis: 5-year interim data from SELECTIONLTE
Oral Presentations·2025
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
˜The œLancet. Gastroenterology & hepatology·2025· 14 cited
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
Gastroenterology·2025· 6 citedOpen Access
Factors associated with response to filgotinib and the prognostic power of faecal calprotectin for ulcerative colitis in the phase 2b/3 SELECTION trial
Digestive and Liver Disease·2025Open Access
page 1 of 63Next →

Frequent Co-authors

William J. Sandborn(34), Paul Rutgeerts(23), Bruce E. Sands(16), Jean‐Frédéric Colombel(15), Stephen B. Hanauer(12), Stefan Schreiber(11), Stephen B. Hanauer(11), Geert D’Haens(11), Richard N. Fedorak(9), Gary R. Lichtenstein(8), Silvio Danese(8), Remo Panaccione(8), Séverine Vermeire(8), Jewel Johanns(7), Walter Reinisch(6), Gert Van Assche(6), Edward V. Loftus(6), Julián Panés(6), Gordon R. Greenberg(6), Daniel Rachmilewitz(5)